ITGBL1 transcriptionally inhibited by JDP2 promotes the development of pancreatic cancer through the TGF-beta/Smad pathway
Open Access
- 1 January 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 55 (1) , e11989
Abstract
Pancreatic cancer (PC) is one of the malignant tumors with the worst prognosis worldwide because of a lack of early diagnostic markers and efficient therapies. Integrin, beta-like 1 (ITGBL1) is a β-integrin-related extracellular matrix protein and is reported to promote progression of some types of cancer. Nevertheless, the function of ITGBL1 in PC is still not clear. Herein, we found that ITGBL1 was highly expressed in PC tissues compared to normal tissues (P<0.05) and PC patients with higher TGBL1 expression showed worse prognosis. PANC-1 and AsPC-1 cells were used for gain/loss-of-function experiments. We found that ITGBL1-silenced cells exhibited decreased proliferation, migration, and invasion abilities and delayed cell cycle, whereas ITGBL1 overexpression reversed these malignant behaviors. ITGBL1 was also demonstrated to activate the TGF-β/Smad pathway, a key signaling pathway in PC progression. Additionally, ITGBL1 expression was found to be suppressed by a suppressor of PC progression, c-Jun dimerization protein 2 (JDP2). Results of dual-luciferase assay indicated that transcription factor JDP2 could inhibit TGBL1 promoter activity. ITGBL1 overexpression inversed the effects of JDP2 up-regulation on cell function. Collectively, we concluded that ITGBL1 may be transcriptionally suppressed by JDP2 and promote PC progression through the TGF-β/Smad pathway, indicating that ITGBL1 may have therapeutic potential for the treatment of PC.Keywords
This publication has 29 references indexed in Scilit:
- ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFβ Signaling PathwayCancer Research, 2015
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- JDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cellsTumor Biology, 2012
- Pancreatic cancerThe Lancet, 2011
- Pancreatic CancerNew England Journal of Medicine, 2010
- The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in miceMolecular Cancer, 2010
- The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3Nucleic Acids Research, 2009
- AP-1 subunits: quarrel and harmony among siblingsJournal of Cell Science, 2004
- Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin β subunitsProceedings of the National Academy of Sciences, 2001
- Cloning and Characterization of a Novel β Integrin-Related cDNA Coding for the Protein TIED (“Ten β Integrin EGF-like Repeat Domains”) That Maps to Chromosome Band 13q33: A Divergent Stand-Alone Integrin Stalk StructureGenomics, 1999